Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Immunotherapy With Racotumomab in Advanced Lung Cancer
Phase 3
- Conditions
- NSCLCLung Cancer, Non-small Cell
- First Posted Date
- 2011-10-26
- Last Posted Date
- 2016-07-29
- Lead Sponsor
- Recombio SL
- Target Recruit Count
- 1082
- Registration Number
- NCT01460472
- Locations
- 🇦🇷
Instituto Médico CER, Quilmes, Buenos Aires, Argentina
🇦🇷Policlínica Privada Instituto de Medicina Nuclear, Bahía Blanca, Argentina
🇦🇷Hospital Italiano, Córdoba, Argentina
News
No news found